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IntrOductIOn
Bladder cancer is one of the most prevalent malignancies of the 
genitourinary system, which comprises 4% of all malignancies [1]. 
Bladder cancer comprises approximately 2-3% of malignancies 
in women and is the ninth leading cause of death due to cancer 
in men [2]. In 25% of cases, bladder cancer occurs in muscle-
invasive form and in 75% of cases in non muscle-invasive form [3]. 
Non-invasive bladder cancer is usually treated with transurethral 
resection (TUR) with or without intravesical therapies and has a 
good prognosis [4], while the radical cystectomy, with or without 
chemotherapy or radiotherapy, should be done for invasive 
tumours [5]. Accurate preoperative staging of the tumour is the 
most important factor in correct management and appropriate 
selection of treatment. Inaccurate staging of tumours is a serious 
problem in the bladder cancer, so it is essential to use acceptable 
imaging modalities [6-8]. Abdominal sonography is not capable 
of detecting location of small lymph nodes and it is very difficult 
to see tumour in obese patients with low bladder volume [9]. 
Because of inability to detect the depth of tumour penetration into 
layers of bladder wall and involvement of adjacent organs, and 
high radiation dose and the need for injection of ionic contrast 
agent, computed tomography (CT) scan is not an ideal modality 
for staging [10]. 
High-contrast resolution, capability of imaging in different views 
and ability to change image contrast by means of various 
sequences have turned Magnetic Resonance Imaging (MRI) into 
the best imaging modality for bladder cancer staging [11]. Method 
 
of dynamic contrast enhanced (DCE)-MRI is a useful technique in 
which rapid enhancement of tumour by uptake of the contrast agent 
is compared to bladder wall, assisting in differentiating tumour from 
surrounding normal tissue. Buy et al., investigated MRI staging of 
bladder carcinoma and its correlation with pathologic findings and 
concluded that MRI showed detection of bladder tumour invasion 
into adjacent organs better than CT scan [12]. Studying method 
of DCE-MRI for staging of superficial bladder cancer, Scattoni et 
al., found that contrast enhancement increased the accuracy of 
the method in superficial cancer staging [13]. Having observed 
high temporal resolution of the method of DCE-MRI, Barentsz et 
al., concluded that use of this method to distinguishing between 
after-biopsy effects and malignancy was possible [14]. Tekes et 
al., evaluated the accuracy of dynamic MRI staging of bladder and 
observed that the accuracy of dynamic MRI staging was high in 
differentiating superficial tumours from invasive tumours and organ-
confined tumours from non-organ-confined tumours of bladder [6]. 
Daneshmand et al., in a retrospective study on staging of invasive 
bladder cancer reported improvement of staging of tumours and 
lymph nodes by DCE-MRI [7]. In a study conducted by Ghafoori et 
al., MRI was reported as a reliable method with high accuracy in 
bladder cancer staging [15].
TNM staging system is a universally accepted method for bladder 
cancer staging [10,16]. Reference standard (or gold standard) to 
determine tumour stage is tumour pathologic assessment after 
radical cystectomy. In this study, the accuracy of method of DCE-
MRI in bladder cancer staging was investigated.
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ABStrAct
Introduction: Dynamic Contrast Enhanced (DCE)-Magnetic 
Resonance Imaging (MRI) is a useful technique in which rapid 
enhancement of tumour by uptake of the contrast agent 
compared to bladder wall.
Aim: To  evaluate   the  accuracy of dynamic gadolinium-en-
hanced  MRI in staging of bladder cancer through differentiating 
superficial tumours from invasive tumours and organ-confined 
tumours from non-organ-confined tumours. In addition, the 
benefits of DCE-MRI in diagnosis of tumour progression steps 
were investigated.
Materials and Methods: This was a quasi-experimental study 
in which 45 patients (95.55% men and 4.45% women) were 
enrolled. Patients with confirmed transitional cell carcinoma 
by histopathology findings were imaged using 1.5 Tesla MRI 
systems. Pathology results were considered as the standard 
reference. Tumour stage was determined by imaging findings 
and compared with pathologic findings after radical cystectomy. 
Data were analysed by SPSS version 16 and the level of 
significance in all tests was considered p<0.001.
results: The most common stage that was seen in pathology 
and MRI findings was T3b. Kappa agreement coefficient between 
MRI and pathology was 0.7 (p<0.001). The accuracy of MRI in 
differentiating superficial tumours (≤T1) from invasive tumours 
(≥ T2a), and organ-confined tumours (≤T2b) from non-organ-
confined tumours (≥T3b) was 0.97 and 0.84, respectively. The 
overall accuracy of MRI was 0.77 (p<0.001). Totally, 10 cases 
of disagreement between MRI and pathological staging were 
found, eight (80%) of which were overestimated and two cases 
(20%) underestimated. MRI detection rate was 0% in stage 
Ta, 100% in stage T1, 66.7% in stage T2, 86.7% in stage T3, 
and 100% in stage T4. The sensitivity and specificity of MRI in 
differentiating superficial tumours from invasive tumours were 
0.97 and 1, respectively, and in differentiating organ-confined 
tumours from non-organ-confined tumours were 0.94 and 0.77, 
respectively. The Spearman's correlation coefficient between 
the signal enhancement slope of time-intensity curves and 
tumour stages was 0.88 (p<0.001).
conclusion: Gadolinium-enhanced MRI is an appropriate and 
useful modality with a high accuracy in determining the stage 
of the bladder cancer. In addition, this method shows extension 
and progression of tumour and tumour invasion depth. 
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parameter plane TR 
(ms)
TE
(ms)
nEX matrix 
size
FoV 
(mm)
Slice 
thickness 
(mm)
number 
of Slices
gap 
(mm)
Flip
angle
band with 
(hz/px)
Ti (1)
Sequence
T1_3D 
VIBEa 
Axial 4.79 1.69 1 138*192 260 3.6 17 0.9 12 300 -
T2W 
FSEb
Sagittal 4240 80 2 256*205 300 5 18 1.2 150 211 -
Axial 2800 77 1 240*320 420 5 17 1 150 200 -
T1W 
FSE
Axial 500 11 1 320*192 336 5 18 1.2 180 178 -
Coronal 610 22 1 320*240 400 4 20 1.5 150 186 -
T2W GREc
True FISPd
Coronal 4.15 2.08 1 256*230 410 4 18 1 47 528 -
STIRe Axial 2800 32 1 256*240 320 5 17 1.2 150 191 160
Coronal 2800 32 2 320*240 380 5 18 1.2 150 191 160
Sagittal 2800 32 1 320*240 380 5 18 1.2 150 195 160
[table/Fig-1]: Parameters of sequences for imaging of bladder and pelvic region.
a volumetric interpolated breath-hold examination; b fast-spin-echo; c gradient recalled echo; d fast imaging with steady-state precession; e short tau inversion recovery
MAterIAlS And MethOdS
Forty-five patients with transitional cell carcinoma of bladder who 
were candidate for radical cystectomy (based on the results of 
sonography, CT scan, or urinalysis) referred to the Imaging Center 
of Shafa for DCE-MRI, from January 2013 to July 2014 with a 
urologist’s coordination. Patients with tumour diagnosed as T0 and 
TX stages and contraindications of MRI such as claustrophobia, 
pacemakers, auditory cochlear and implants and other metal 
objects in their body were excluded from the study. Patients’ 
participation in the study was voluntary. The study protocol and 
objectives were explained to all the patients and written informed 
consent was obtained from them.
All the patients were imaged with an 18-channel 1.5 Tesla MRI 
scanner (MAGNETOM Avanto 18-channel SQ engine Siemens 
Healthcare, Erlangen, Germany) using a phased array coil. MRI 
protocol was as follows: axial, coronal and sagittal T1-weighted 
stir, axial T2-weighted fast spin echo, axial, coronal T1 fast spin 
echo, axial three-dimension volumetric interpolated breath-hold 
examination before and after intravenous injection of gadolinium 
(0.1 mmol/kg) [Table/Fig-1]. In order to prevent significant difference 
in arrival time of contrast agent and possible effect on the results, 
one person did imaging for all patients and manual injection 
of contrast agent in all the the patients lasted for 5-7 seconds 
with the rate of 3 cc/sec by the same needle. Starting injection 
of contrast agent was done simultaneously with data collection. 
Time-intensity curves were obtained from signal intensity values 
of the plotted ROIs. ROIs were drawn in the region of maximum 
enhancement and included five pixels [Table/Fig-2a&b].
A radiologist who was blind to pathology staging results reviewed 
MRI images. Tumour staging was done and compared with the 
pathologic staging. In all the patients, radical cystectomy was 
selected as the treatment. For staging, the following guideline was 
used:
If the hypointense line at the base of tumour is preserved, it 
indicates an intact muscle layer and the tumour stage is T1 [Table/
Fig-3] [17]; an irregular, shaggy inner margin of the hypointense 
line (muscle layer) indicates the stage T2a tumour; existence 
of a discontinuous hypointense line, without perivesical fat 
infiltration corresponds to the stage T2b [Table/Fig-4]; a lesion 
with an external irregular border with signal similar to tumour in 
the perivesical fat is defined as stage T3 [Table/Fig-5a&b]; and 
invasion to pelvic wall or adjacent organs indicates the stage T4 
tumour [Table/Fig-6] [7,15,18]. As the depth of tumour invasion is 
highly effective on treatment planning, only T stage tumours were 
evaluated. Since, differentiating superficial tumours from invasive 
tumours is an important factor in appropriate management of 
cancer treatment, the accuracy of MRI in differentiating superficial 
tumours from invasive tumours was studied. For this purpose, we 
divided tumours into two groups: superficial (≤T1) and invasive 
(≥T2a) [6]. Patients with extravesical tumours have significantly 
higher recurrence rate, worse prognosis, and shorter survival than 
patients with organ-confined tumours [19], and differentiating 
between these two types of tumours is essential; thus, we also 
evaluated accuracy of MRI in differentiating between organ-
confined tumour (≤T2b) and non-organ-confined (≥T3b).
ethIcS
This study protocol was approved the ethics committee of the 
university. 
StAtIStIcAl AnAlySIS
The mean and variance were used to describe the quantitative 
data, and percentage and frequency were used for qualitative 
data. To assess the accuracy of DCE-MRI sensitivity, specificity, 
positive predictive value, negative predictive value, and positive 
and negative likelihood, the ratio between MRI and pathological 
findings was obtained; kappa agreement coefficient between MRI 
and pathology was calculated. Spearman's correlation coefficient 
was calculated to examine the correlation between tumour stage 
and slope of time-intensity curve. Data were analysed by SPSS 
version 16 and the level of significance in all tests was considered 
p<0.001.
reSultS
In this study, 43 male patients (95.55%) and two female patients 
(4.45%) were studied. Range of the patients’ ages was 43-63 years 
with mean of 52.07± 6.51 years. All tumours were transitional cell 
carcinoma in the histopathologic results. The most common stage 
seen in the MRI results was T3b (n: 19, 42%) [Table/Fig-7]. In the 
histopathologic findings, the most diagnosed stage in the patients 
was T3b (n: 15, 33%), as well [Table/Fig-7]. In addition three 
patients (6%) with stage T1, five patients (11%) with stage T2a, 10 
patients (22%) with stage T2b and 8 patients (17%) with stage T4a 
were diagnosed. For the location of the tumour, the most common 
location of tumour were the left wall of the bladder, followed by 
posterior wall, anterior wall, base and dome of the bladder. Kappa 
agreement coefficient between MRI and pathology was obtained 
0.7 (p<0.001). Totally 10 cases of mismatch between MRI and 
pathological staging were observed that according to [Table/Fig-7], 
in eight cases (80%) were overestimated and in two cases (20%) 
were underestimated. Detection rate of MRI was 0% in stage Ta, 
100% in stage T1, 66.7% in stage T2, 86.7% in stage T3, and 
100% in stage T4. Sensitivity and specificity of MRI (compared 
with histology as the gold standard) in differentiating superficial 
tumours (Ta, T1) from deep tumours (T2, T3, T4) were derived 
0.97 and 1, respectively [Table/Fig-8]. Moreover, sensitivity and 
specificity of MRI in differentiating organ-confined tumours (Ta, 
T1, and T2) from non-organ-confined tumours (T2, T3, and T4) 
were obtained 0.94 and 0.77, respectively [Table/Fig-9]. Accuracy 
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Result point Estimate lower Ci a Upper Ci
Sensitivity 0.9767 0.9317 1.0218
Specificity 1 1 1
Positive Predictive Value 1 1 1
Negative Predictive Value 0.6667 0.1332 1.2001
Positive Likelihood Ratio infinity - -
Negative Likelihood Ratio 0.0233 0.0034 0.1614
diagnostic index point Estimate lower Ci a Upper Ci
Sensitivity 0.9444 0.8386 1.0503
Specificity 0.7778 0.6210 0.9346
Positive Predictive Value 0.7391 0.5597 0.9186
Negative Predictive Value 0.9546 0.8675 1.0416
Positive Likelihood Ratio 4.25 2.0801 8.6835
Negative Likelihood Ratio 0.0714 0.0105 0.4850
mRi Total
T1 T2a T2b T3b T4a
P
at
ho
lo
gy
Ta 1 0 0 0 0 1
T1 1 0 0 0 0 1
T2a 1 5 0 5 0 11
T2b 0 0 9 1 0 10
T3b 0 0 1 13 1 15
T4a 0 0 0 0 7 7
Total 3 5 10 19 8 45
of MRI in differentiating superficial tumours (≤T1) from invasive 
tumours (≥ T2a), and organ-confined tumours (≤T2b) from non-
organ-confined tumours (≥T3b) was 0.97 and 0.84, respectively. 
The overall accuracy of MRI in this study was 77.0 (p<0.001). 
Spearman's correlation coefficient between signal enhancement 
slope of time-intensity curves and stage of tumours was obtained 
0.88 (p<0.001) [Table/Fig-10].
dIScuSSIOn
In our study, the most diagnosed MRI and pathologic stage was 
T3b. In other studies, the most commonly diagnosed stage was T1. 
This difference may be due to the fact that our patients’ referring 
was not early and the treatment started later [20,21]. According 
to the MRI findings and comparison of stages with pathologic 
findings, there was totally 10 mismatches between MRI findings 
and pathology, two (20%) of which were underestimated and eight 
(80%) were overestimated.
In a study by Tekes et al., consistent with our study, most cases 
of mismatches (32%) were overestimated (p<0.001) [6]. Buy et 
[table/Fig-7]: Pathology and magnetic resonance imaging results.
[table/Fig-2]: a) Axial contrast-enhanced 3D volumetric interpolated breath-hold examination magnetic resonance image in a T1 stage tumour with ROI; b) Time-intensity 
curve of the ROI. [table/Fig-3]: Coronal contrast enhanced T1-weighted magnetic resonance image in 56-year-old man with transitional cell carcinoma of the bladder. Contrast 
enhanced images illustrate an intense enhancement of the tumour with uninterrupted detrusor muscle layer and intact perivesical fat, and mucosal involvement, staged as T1 
tumour on MRI and pathology. [table/Fig-4]: Coronal T1-weighted short tau inversion recovery image in 49-year-old man with transitional cell carcinoma of the bladder. Images 
show disrupted detrusor muscle without perivesical fat infiltration. These findings imply that tumour stage is T2b. The pathology stage was the same.
[table/Fig-5]: a) Sagittal T1-weighted short tau inversion recovery; b) Axial fat suppressed T1-weighted magnetic resonance images in 45-year-old woman with correctly staged 
T3b transitional cell carcinoma of the bladder. Images show deep invasion of the tumour to right bladder wall, bladder dome, and perivesical fat infiltration.
[table/Fig-6]: Coronal contrast enhanced T1-weighted magnetic resonance image in 50-year-old man with transitional cell carcinoma of the bladder. Images show invasion to 
the prostate gland. This was staged as T4a on MRI. The first transurethral resection staged this as T2b; but radical cystectomy confirmed a T4 tumour.
[table/Fig-8]: Diagnostic indices of magnetic resonance imaging versus 
histopathology in differentiation of superficial and deep tumours.
a Confidence interval.
[table/Fig-9]: Diagnostic indices of magnetic resonance imaging versus
histopathology in differentiation of organ-confined and non-organ-confined tumours.
a Confidence interval.
[table/Fig-10]: Correlation between slopes of time-intensity curve with tumours stage.
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al., in a study with a 5.0 Tesla system without injection of contrast 
agent fewer of patients, as compared to our study, reported 
underestimation as 33% (p<0.001) [12]. In some studies, such as 
Scattoni et al., and Tekes et al., because of consecutive errors in 
determining stage of the bladder cancer, estimates were usually 
reported as overestimated [6,13].
Another reason for more overestimation than underestimation 
in our study was abnormal signals in perivesical fat in tumour 
location that were incorrectly identified as tumour invasion. For 
example, tumours were reported as T3b in five patients in stage 
T2b. Vascular hyperaemia adjacent to the tumour or inflammatory 
process that occurred in the tissues around bladder following TUR 
biopsy of tumours could cause these abnormal signals. In addition, 
chemical shift artifact at the bladder-perivesical fat junction may 
obscure the bladder wall or be regarded as pathological.
One case of underestimation occurred between T1 and T2a, 
because of underestimation of tumour invasion into hyposignal 
muscle layer of the bladder. Another case was between T3b and 
T2b; because of low signal to noise ratio of the image and slight 
movement of the patient, perivesical invasion remained hidden 
from sight of radiologist. 
Accuracy of DCE-MRI in bladder cancer staging has been reported 
52-93% [6,22] which could  increase up to 73-100% with injection 
of contrast agent [6]. Accuracy of 77% in our study indicates a 
good correlation between MRI and pathology. In the study of Sohn 
et al., the accuracy of dynamic MRI staging was reported 83% 
that was slightly higher than accuracy obtained in our study, which 
could be due to greater number of samples in Sohn et al., study 
[23].
In study of Nguyen et al., use of a three Tesla scanner could be 
the reason for accuracy of 81% [24]. It has been demonstrated 
that tumours were understaged by TUR [18]. In addition, the 
weakness of MRI in detection of tumours in stage T3a (because of 
microscopic invasion of tumour) may also be the reason for lower 
accuracy obtained in the present study.
In the present study, kappa agreement coefficient was 0.7, and 
sensitivity and specificity in differentiating superficial tumours 
from invasive tumours were 97% and 100%, and in differentiating 
of organ-confined tumours from non-organ-confined tumours 
were 94% and 77%, respectively, which could be considered 
as acceptable and consistent with the results of Tekes et al. 
(95% sensitivity, 55% specificity) [6]. Takeuchi et al., achieved 
sensitivity and specificity of 80% and 92%, respectively, for MRI in 
differentiating organ-confined tumours from non-organ-confined 
tumours [20]. Abou-El-Ghar et al., observed that the accuracy 
of diffusion imaging in staging of organ-confined tumours was 
significantly higher than T2W imaging [25]. 
Gadolinium enhancement has a considerable effect on increasing 
the accuracy, sensitivity, and specificity [15,18]. By observing high 
temporal resolution of DCE-MRI, Barentsz et al., concluded that 
distinguishing between after-biopsy effects and malignancy was 
likely [14]. Kim et al., have concluded that dynamic gadolinium-
enhanced MRI significantly increases the accuracy of staging of 
bladder cancer [14,17].
The present study showed that the MRI accuracy in differentiating 
superficial tumours from invasive tumours was 97% and in 
differentiating organ-confined tumours from non-organ-confined 
tumours was 84%, which is consistent with Tekes et al., study 
with regard to differentiating organ-confined tumours from non-
organ-confined tumours (82% accuracy) [6].
A point that was considered in the present study rather than 
previous studies was the correlation of tumour stage with slope 
of time-intensity curves of tumour in dynamic images. Tumour 
vessels are not normal and tumour epithelial cells within the 
inner surface of tumour develop gaps. The blood leaking out 
from the distance between endothelial cells, permeability, and 
neovascularity of tumour increases abnormally and tumours with 
higher angiogenesis have higher risk of local recurrence. By DCE, 
the peak of the curve occurs in areas with uptake of contrast, 
which represents increased permeability, abnormal vascularity, 
and higher malignancy of tumour [26]. The positive correlation 
and significant relationship between tumour stage and signal 
enhancement slope of tumour time-intensity curves suggests that 
the peak time-intensity curves occur with greater slope as tumour 
stage increases. This relationship can be helpful in diagnosis of 
severity and progression of tumours, as the slope of the curves is 
steeper in the non-organ-confined tumours. 
cOncluSIOn
In this study, despite small differences between the results of the 
MRI and pathology, DCE-MRI was found to be an accurate modality 
for assessment of T staging, and its routine use in bladder cancer 
staging causes significant improvement of diagnostic accuracy of 
the staging and treatment planning and hence improvement of the 
prognosis of patients and their survival rates. Furthermore, the use 
of MRI systems with higher magnetic field and imaging techniques 
standardized with higher resolution could further enhance the 
accuracy of the method. Comparison of MRI data with CT-scan 
findings of patients is recommended in future studies. Further 
studies with larger sample size may also help to validate the results 
of this study.
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